Dec.14 -- Zymergen Inc. Chief Executive Officer Joshua Hoffman discusses the biotechnology research firm's plans to utilize therecent $400 million round of investment in the startup. He speaks with Bloomberg's Emily Chang on "Bloomberg Technology."